Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00573872 · ClinicalTrials.gov registry record · NA

A Phase II Study of Spinal Radiosurgery

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT00573872 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 43 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00573872, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

Phase I of the study (motion and quality assurance \[QA\] study) is being used to determine intrafraction target motion and define quality assurance procedures for single fraction spinal radiosurgery. The Phase II portion of the study is being used to estimate the palliative response (pain or relief of neurologic symptoms) and local control for single fraction radiosurgery delivered with TomoTherapy and to assess the acute and late toxicity of spinal radiosurgery.

Interventions

  • RADIATION Radiosurgery

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2005-04
Est. Completion 2016-09
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT00573872

The ClinicalTrials.gov registry entry for NCT00573872 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Radiosurgery is the first listed.

NCT00573872 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00573872 about?

NCT00573872 is a clinical study titled "A Phase II Study of Spinal Radiosurgery". Phase I of the study (motion and quality assurance \[QA\] study) is being used to determine intrafraction target motion and define quality assurance procedures for single fraction spinal radiosurgery. The Phase II portion of the study is being used to estimate the palliative response (pain or relief...

What is the current status of trial NCT00573872?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2005-04. Estimated completion is 2016-09.

What interventions are being tested in trial NCT00573872?

The interventions under investigation include: Radiosurgery (RADIATION).

Who is sponsoring clinical trial NCT00573872?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.